Gentherm Inc
Business
Gentherm Inc is a global developer and manufacturer of thermal management and pneumatic comfort technologies for the automotive industry and patient temperature management systems for healthcare. Its main products include Climate Control Seats®, heated interior systems, thermoelectric devices, battery performance and cable solutions, pneumatic lumbar and massage systems, valve technologies, electronic control units, and a portfolio of patient temperature management devices. The company reports two principal segments—Automotive and Medical—covering vehicle comfort, battery and valve systems and clinical temperature management. Gentherm sells primarily to automotive OEMs and Tier 1 suppliers, aftermarket distributors, and healthcare providers across North America, Europe, Asia and other global markets, with products used in hospitals in the U.S., China, Germany and Brazil.
Summary from filing dated 2025-02-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Product revenues | 1,499 | 1,456 | 1,469 | 1,205 | 1,046 | |
| Cost of sales | 1,136 | 1,090 | 1,117 | 931 | 743 | |
| Gross margin | 362 | 366 | 352 | 274 | 304 | |
| Net research and development expenses | 95 | 89 | 94 | 86 | 75 | |
| Selling, general and administrative expenses | 170 | 155 | 156 | 133 | 110 | |
| Restructuring expenses, net | 12 | 13 | 5 | 637,000 | 4 | |
| Loss on sale of land and building, net | 2 | — | — | — | — | |
| Impairment of intangible assets and property and equipment | — | 3 | — | 6 | — | |
| Impairment of goodwill | — | — | 20 | — | — | |
| Total operating expenses | 279 | 259 | 274 | 225 | 189 | |
| Operating income | 83 | 107 | 77 | 48 | 115 | |
| Interest expense, net | −14 | −15 | −15 | −4 | −3 | |
| Foreign currency (loss) gain | −28 | 10 | −6 | −7 | 1 | |
| Other (loss) income | −5 | 951,000 | −2 | 1 | 117,000 | |
| Earnings before income tax | 36 | 102 | 55 | 38 | 114 | |
| Income tax expense | 18 | 37 | 15 | 14 | 20 | |
| Net income | 18 | 65 | 40 | 24 | 93 | |
| Basic earnings per share | 0.6 | 2.08 | 1.23 | 0.74 | 2.82 | |
| Diluted earnings per share | 0.59 | 2.06 | 1.22 | 0.73 | 2.79 | |
| Weighted average number of shares basic | 31 | 31 | 33 | 33 | 33 | |
| Weighted average number of shares diluted | 31 | 31 | 33 | 34 | 34 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 161 | 134 | 150 | 154 | 191 | |
| Accounts receivable, net | 281 | 258 | 254 | 247 | 183 | |
| Inventory, net | 253 | 227 | 206 | 218 | 159 | |
| Other current assets | 82 | 64 | 78 | 65 | 33 | |
| Total current assets | 777 | 684 | 688 | 684 | 566 | |
| Property and equipment, net | 271 | 253 | 245 | 244 | 155 | |
| Goodwill | 109 | 100 | 104 | 120 | 66 | |
| Other intangible assets, net | 53 | 57 | 66 | 74 | 38 | |
| Operating lease right-of-use assets | 57 | 44 | 27 | 30 | 24 | |
| Deferred income tax assets | 94 | 75 | 82 | 70 | 70 | |
| Other non-current assets | 37 | 35 | 22 | 17 | 17 | |
| Total assets | 1,396 | 1,248 | 1,234 | 1,239 | 935 | |
| Accounts payable | 260 | 227 | 216 | 182 | 123 | |
| Current lease liabilities | 10 | 8 | 8 | 7 | 6 | |
| Current maturities of long-term debt | 73,000 | 137,000 | 621,000 | 2 | 3 | |
| Other current liabilities | 134 | 106 | 101 | 94 | 82 | |
| Total current liabilities | 404 | 340 | 325 | 286 | 213 | |
| Long-term debt, less current maturities | 189 | 220 | 222 | 233 | 36 | |
| Non-current lease liabilities | 48 | 37 | 16 | 21 | 20 | |
| Pension benefit obligation | 4 | 4 | 3 | 4 | 7 | |
| Other non-current liabilities | 31 | 29 | 23 | 25 | 6 | |
| Total liabilities | 676 | 631 | 590 | 567 | 282 | |
| No par value, 55,000,000 shares authorized 30,526,231 and 30,788,639 issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 6 | 2 | 51 | 123 | 119 | |
| Paid-in capital | 2 | 4 | — | 5 | 6 | |
| Accumulated other comprehensive loss | −964,000 | −85 | −30 | −46 | −37 | |
| Accumulated earnings | 714 | 696 | 624 | 591 | 566 | |
| Total shareholders equity | 720 | 617 | 645 | 672 | 654 | |
| Total liabilities and shareholders equity | 1,396 | 1,248 | 1,234 | 1,239 | 935 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 53 | 53 | 51 | 44 | 39 | |
| Deferred income taxes | −22 | 11 | −13 | −7 | −150,000 | |
| Stock based compensation | 12 | 10 | 12 | 7 | 15 | |
| Provisions for inventory | 7 | 6 | 7 | 16 | 2 | |
| Loss (gain) on disposition of property and equipment | 3 | −2 | 721,000 | 771,000 | 973,000 | |
| Other non-cash items, including unrealized foreign currency loss (gain) | 35 | −1 | 3 | 721,000 | −271,000 | |
| Accounts receivable, net | −9 | −12 | −4 | −44 | 25 | |
| Inventory | −22 | −34 | 7 | −40 | −42 | |
| Other assets | −18 | −45 | −26 | −12 | 10 | |
| Accounts payable | 28 | 16 | 31 | 28 | 8 | |
| Other liabilities | 32 | 39 | −8 | −9 | −8 | |
| Net cash provided by operating activities | 117 | 110 | 119 | 15 | 143 | |
| Purchases of property and equipment | −56 | −73 | −38 | −40 | −38 | |
| Proceeds from the sale of property and equipment | 4 | 8 | 391,000 | 248,000 | 22,000 | |
| Proceeds from deferred purchase price of factored receivables | 745,000 | 13 | 14 | 6 | — | |
| Cost of technology investments | −1 | −955,000 | −815,000 | −495,000 | −8 | |
| Net cash used in investing activities | −52 | −54 | −24 | −240 | −49 | |
| Borrowings on debt | 112 | 68 | 60 | 207 | — | |
| Repayments of debt | −143 | −71 | −72 | −13 | −153 | |
| Proceeds from the exercise of Common Stock options | — | 6 | 263,000 | 2 | 8 | |
| Taxes withheld and paid on employees' share-based payment awards | −1 | −3 | −3 | −5 | −4 | |
| Cash paid for the repurchase of Common Stock | −10 | −52 | −91 | — | −20 | |
| Net cash used in financing activities | −42 | −52 | −106 | 190 | −169 | |
| Foreign currency effect | 5 | −20 | 7 | −2 | −3 | |
| Net cash increase (decrease) in cash and cash equivalents | 27 | −16 | −4 | −37 | −78 | |
| Cash paid for taxes | 37 | 21 | 23 | 22 | 15 | |
| Cash paid for interest | 13 | 13 | 13 | 6 | 2 | |
| Period-end balance of accounts payable for property and equipment | 6 | 5 | 8 | 3 | 2 | |
| Deferred purchase price of receivables factored in the period | — | 9 | 14 | 4 | — |